title: Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost?
authors.affiliation: Cardiology Department, Ioannina University Hospital, Greece. igoudev@cc.uoi.gr
authors.forename: John
authors.initials: J
authors.lastname: Goudevenos
authors.forename: Athanasios
authors.initials: A
authors.lastname: Pipilis
authors.forename: Panos
authors.initials: P
authors.lastname: Vardas
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000191:economics*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D016527:Drug Costs; D006801:Humans; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants